Cargando…

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis

Cryptococcal Meningitis (CM) is uniformly fatal if not treated, and treatment options are limited. We previously reported on the activity of APX2096, the prodrug of the novel Gwt1 inhibitor APX2039, in a mouse model of CM. Here, we investigated the efficacy of APX2039 in mouse and rabbit models of C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giamberardino, Charles D., Schell, Wiley A., Tenor, Jennifer L., Toffaletti, Dena L., Palmucci, Julia R., Marius, Choiselle, Boua, Jane-Valeriane K., Soltow, Quinlyn, Mansbach, Robert, Moseley, M. Arthur, Thompson, J. Will, Dubois, Laura G., Hope, William, Perfect, John R., Shaw, Karen Joy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765414/ https://www.ncbi.nlm.nih.gov/pubmed/36222509 http://dx.doi.org/10.1128/mbio.02347-22

Ejemplares similares

168. Efficacy of the Novel gwt1 Inhibitor APX2039 in a Rabbit Model of cryptococcus Meningitis
por: Shaw, Karen J, et al.
Publicado: (2020)

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D., et al.
Publicado: (2023)

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
por: Shaw, Karen Joy, et al.
Publicado: (2018)

Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017)

605. Efficacy and pharmacokinetics-pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D, et al.
Publicado: (2022)

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
por: Kovanda, Laura L., et al.
Publicado: (2019)

Fungal Cytological Profiling of Candida albicans Exposed to Diverse Antifungal Agents Including the Novel Gwt1 inhibitor APX001A
por: Sharp, Marc, et al.
Publicado: (2017)

Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species
por: Kapoor, Mili, et al.
Publicado: (2019)

APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia
por: Viriyakosol, Suganya, et al.
Publicado: (2019)

In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis
por: Charalambous, Lefko, et al.
Publicado: (2017)

Gene Expression of Diverse Cryptococcus Isolates during Infection of the Human Central Nervous System
por: Yu, Chen-Hsin, et al.
Publicado: (2021)

The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis
por: Chen, Yuan, et al.
Publicado: (2014)

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
por: Hope, William, et al.
Publicado: (2019)

Landscape of gene expression variation of natural isolates of Cryptococcus neoformans in response to biologically relevant stresses
por: Yu, Chen-Hsin, et al.
Publicado: (2019)

Assessing the virulence of Cryptococcus neoformans causing meningitis in HIV infected and uninfected patients in Vietnam
por: Thanh, Lam Tuan, et al.
Publicado: (2020)

Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
por: Lestner, Jodi, et al.
Publicado: (2017)

Molecular mechanisms of cryptococcal meningitis
por: Liu, Tong-Bao, et al.
Publicado: (2012)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Structural and In Vivo Studies on Trehalose-6-Phosphate Synthase from Pathogenic Fungi Provide Insights into Its Catalytic Mechanism, Biological Necessity, and Potential for Novel Antifungal Drug Design
por: Miao, Yi, et al.
Publicado: (2017)

Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil
por: Ponzio, Vinicius, et al.
Publicado: (2019)

Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome
por: Sephton-Clark, Poppy, et al.
Publicado: (2022)

Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
por: Jung, Myunghwan, et al.
Publicado: (2019)

Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion
por: Tenor, Jennifer L., et al.
Publicado: (2015)

Cryptococcal meningitis: epidemiology and therapeutic options
por: Sloan, Derek J, et al.
Publicado: (2014)

Hearing Loss in Cryptococcal Meningitis Survivors
por: Lofgren, Sarah, et al.
Publicado: (2017)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Cryptococcal Meningitis in an Apparent Immunocompetent Patient
por: Poley, Marian, et al.
Publicado: (2019)

Microglia are not protective against cryptococcal meningitis
por: Mohamed, Sally H., et al.
Publicado: (2023)

Cryptococcal Meningitis in an Apparent Immunocompetent Host
por: Molina, Guarina, et al.
Publicado: (2023)

Connecting Cryptococcal Meningitis and Gut Microbiome
por: Ma, Yuanyuan, et al.
Publicado: (2023)

Absorption, Distribution, and Excretion of (14)C-APX001 after Single-Dose Administration to Rats and Monkeys
por: Mansbach, Robert, et al.
Publicado: (2017)

Pleiotropic Effects of Deubiquitinating Enzyme Ubp5 on Growth and Pathogenesis of Cryptococcus neoformans
por: Fang, Wei, et al.
Publicado: (2012)

Return of meningeal symptoms in a patient treated for cryptococcal meningitis
por: Huits, Ralph M. H. G., et al.
Publicado: (2007)

From a Digital Bottle: A Message to Ourselves in 2039
por: Jadad, Alejandro R, et al.
Publicado: (2019)

2039. Antibiotic Stewardship in Burn and Chronic Wound Centers in Nepal
por: Nauriyal, Varidhi, et al.
Publicado: (2019)

Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
por: Nanfuka, Vivien, et al.
Publicado: (2021)

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi
por: Kanyama, Cecilia, et al.
Publicado: (2020)

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Transcriptional Profiles Elucidate Differential Host Responses to Infection with Cryptococcus neoformans and Cryptococcus gattii
por: Holcomb, Zachary E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3k2n6b5gk1ucqnr1uh2ch9egva